Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Tags:
Sandoz, Zarxio, biosimilars, Novartis, drug launches, Amgen, Neupogen
Amgen swings for EU approval with its new kidney drug
Fierce Biotech
Thu, 09/3/15 - 11:47 am
Tags:
Amgen, Europe, kidney dialysis, etelcalcetide
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount
Yahoo/Reuters
Thu, 09/3/15 - 08:45 am
Tags:
Novartis, biosimilars, Amgen, Neupogen, Zarxio, Sandoz
Amgen Inc.'s FDA Approval Holds Blockbuster Potential
Motley Fool
Thu, 09/3/15 - 08:44 am
Tags:
Amgen, FDA, Repatha
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Tags:
Amgen, Neupogen, biosimilars, Zarxio, Novartis, Sandoz
2 major insurers draw lines in the sand for pricey PCSK9 coverage
BioPharma Dive
Wed, 09/2/15 - 12:34 pm
Tags:
PCSK9 inhibitors, insurers, Regeneron, Sanofi, Amgen, Praluent, Repatha
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Tags:
Novartis, Amgen, migraines, Alzheimer's disease, R&D, CNP520, AMG 334
Amgen's bone drug succeeds in late-stage study
Yahoo/Reuters
Tue, 09/1/15 - 06:40 pm
Tags:
Amgen, osteoporosis, romosozumab
Amgen Finds Data Falsified in Obesity-Diabetes Study Featuring Grizzly Bears
WSJ Online
Tue, 09/1/15 - 06:34 pm
Tags:
Amgen, diabetes, obesity
Approval Of Repatha May Give Amgen A $5B Boost
Seeking Alpha
Mon, 08/31/15 - 05:28 pm
Tags:
Repatha, Amgen, PCSK9 inhibitors, Praluent, Sanofi, Regeneron
Amgen, Inc. Or Regeneron Pharmaceuticals Inc - Who Would Win The PCSK-9 Race?
Bidness, ETC
Mon, 08/31/15 - 09:06 am
Tags:
PCSK9 inhibitors, Amgen, Regeneron, Repatha, Praluent
​Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Bizjournals.com
Sun, 08/30/15 - 02:04 pm
Tags:
Alnylam, Amgen, The Medicines Company, PCSK9 inhibitors, ALN-PCSsc, Repatha, Praluent
Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool
Barron's
Sat, 08/29/15 - 09:03 am
Tags:
Gilead Sciences, Amgen, biotech
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
Forbes
Fri, 08/28/15 - 08:19 am
Tags:
drug pricing, Repatha, Praluent, Sanofi, Regeneron, Amgen, PCSK9 inhibitors
FDA approves Amgen's cholesterol drug Repatha
Yahoo/Reuters
Thu, 08/27/15 - 05:29 pm
Tags:
FDA, Amgen, Repatha, PCSK9 inhibitors
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
Tags:
JNJ, daratumumab, Multiple Myeloma, Kyprolis, Amgen, Genmab, elotuzumab, AbbVie, Bristol-Myers Squibb
Can Sprout's Addyi shrug off serious side effects? These blockbusters did
Fierce Pharma Marketing
Wed, 08/26/15 - 09:24 am
Tags:
Sprout Pharmaceuticals, Addyi, female sexual dysfunction, side effects, Advair, GSK, Amgen, Epogen, Merck, Fosamax
Amgen files for approval of parathyroid disorder drug
Yahoo/AP
Tue, 08/25/15 - 04:46 pm
Tags:
Amgen, etelcalcetide, chronic kidney disease
Who should Allergan buy next?
Fierce Pharma
Tue, 08/25/15 - 02:10 pm
Tags:
Allergan, M&A, AbbVie, Shire, Amgen, Biogen
How Big Biotech Spents It’s Money
Barron's
Fri, 08/21/15 - 05:23 pm
Tags:
biotech, Amgen, Biogen, Regeneron, Celgene, Gilead, Alexion

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.